Objective-Progesterone and adipoQ receptor (PAQR) 10 and PAQR11 are 2 highly homologous genes involved in compartmentalized Ras signaling in the Golgi apparatus. The aim of this study was to investigate the physiological functions of PAQR10 and PAQR11. Methods and Results-We used zebrafish as a model system to analyze the potential function of PAQR10/PAQR11. The expression profiles of PAQR10 and PAQR11 in zebrafish embryos are overlapping in many areas, but only PAQR11 is expressed in the developing heart. Knockdown of PAQR11 but not PAQR10 in zebrafish embryos causes cardiac developmental defects, including dilation of cardiac chambers, abnormal heart looping, disruption of atrioventricular cushion formation, heart edema, and blood regurgitation. PAQR11 knockdown markedly reduces the number and proliferation rate of cardiomyocytes and alters the morphology of myocardial cells during early heart development. The cardiac defects caused by PAQR11 knockdown can be phenocopied by MEK inhibitors and a dominant negative Ras. Furthermore, constitutively active Ras and especially a Golgi-localized but not a plasma membrane-localized Ras are able to rescue the cardiac defects caused by PAQR11 knockdown. Conclusion-This study not only provides in vivo evidence that PAQR11 plays a critical role in heart morphogenesis but also pinpoints the importance of compartmentalized Ras signaling during development. (Arterioscler Thromb Vasc Biol. 2012;32:2158-2170.)
T he heart is the first organ to form and function in the vertebrate embryo and consists of 2 layers with myocardium (outer muscle layer) and endocardium (inner endothelial layer) during early development. 1 The overall shape and positioning of the heart vary among vertebrate species, whereas the developmental process is conserved in many aspects. 2 In all vertebrates, the myocardial and endocardial progenitors arise at the ventral and lateral regions of the embryos. After involution during the early stages of gastrulation, the heart precursors migrate towards the anterior-lateral regions and converge at the midline, where they form the linear heart tube. 1, 2 Afterwards, complex morphogenetic movements transform this simple tube into a looped organ, with the ventricle positioned to the right of the atrium. The looping of the heart is the first morphological manifestation of the left-right asymmetry during embryogenesis. 1 Several mechanisms have been suggested to contribute to cardiac looping, such as cell proliferation, cell organization, and cell morphology changes. 3 Many model systems, including Drosophila, Xenopus, zebrafish, chicken, and mouse, have been used to understand the molecular mechanisms of heart development. 1, [4] [5] [6] Among these species, zebrafish has offered several distinct advantages as an excellent genetic and embryological model system for analyzing heart development. External fertilization, rapid development, and the transparent body of zebrafish facilitate extensive observation during heart development. 1, 7 Furthermore, zebrafish embryos do not need a complete and functional cardiovascular system during development, allowing for careful analysis of cardiac defects without the confounding context of a dying embryo. 8 In addition, its small size, fecundity, and short generation time make it possible to carry out large-scale genetic and drug screening. 9 Thus, using the zebrafish system, a large array of key regulators and signaling components have been discovered to possess essential roles during heart development, such as those involved in Ras/extracellular signal-regulated kinase (ERK) signaling cascade. Studies with zebrafish embryos upon morpholino knockdown of Raf1, a downstream effector of Ras, demonstrated the need of Raf1 for the development of normal heart formation and function. 10 More recently, knockdown of zebrafish nf1a and nf1b, proteins that modulate the activity of Ras, results in cardiovascular defects during zebrafish embryogenesis, suggesting that Ras/ERK signaling plays an essential role in heart development. 11 Progesterone and adiponectin receptors (PAQR) family is characterized as possessing an ancient 7-transmembrane motif. 12 This family is composed of 11 members (PAQR1 to PAQR11) in mammals and shares a significant sequence identity with ancient bacterial hemolysin-like proteins, suggesting that they played important roles during evolution. 12 All the members of the PAQR family are predicted to contain 7 transmembrane domains but are structurally distinct from traditional G protein-coupled receptor. For example, it has been demonstrated that the N-termini of PAQR1, PAQR2, and PAQR3 are facing the cytoplasm in topology. 13, 14 The physiological roles and molecular functions of the PAQR family have been explored recently. Adiponectin receptors (PAQR1 and PAQR2) are the first 2 members of the family discovered in 2003 and they play an important role in the regulation of glucose and lipid metabolism. 13 PAQR3 was found to sequester Raf1 kinase to the Golgi apparatus whereby inhibiting Ras-to-ERK signaling and PAQR3 was renamed as Raf kinase trapping to Golgi. 15 A series of studies also indicate that PAQR3/Raf kinase trapping to Golgi functions as a potential tumor suppressor by negative regulation on Ras signaling pathway. [16] [17] [18] [19] PAQR10 and PAQR11 are 2 members of the PAQR family with high sequence homology to each other. PAQR11 was previously identified in mRNA differential display and proposed to have an effect on macrophage differentiation. 20 Our recent studies reveal that PAQR10 and PAQR11 are exclusively located in the Golgi apparatus and are involved in the spatial regulation of Ras/ERK signaling by tethering Ras proteins to the Golgi apparatus. 21 This study has provided additional evidence that subcellular compartmentalization plays an important role in modulating Ras-mediated signaling cascade. 22, 23 We also found that PAQR10 and PAQR11 are implicated in the delayed and prolonged Ras signaling. 21 In addition, we demonstrated that Golgi localization is essential for PAQR10 to regulate Ras signaling cascade. 21 However, the physiological functions of PAQR10 and PAQR11 are still largely unknown. In this study, we examined the roles of PAQR10 and PAQR11 during zebrafish embryogenesis.
Materials and Methods
A detailed description of Materials and Methods is provided in the online-only Data Supplement.
Raising and Staging of Zebrafish Embryos
Wild-type AB, Tg(fli1:EGFP), 24 Tg(cmlc2:DsRed2-nuc) f2, 25 and Tg(cmlc2:egfp) 26 zebrafish were obtained from the Zebrafish International Resource Center (ZIRC, Eugene, OR) and maintained in the National Zebrafish Resources of China (NZRC, Shanghai, China) with an automatic fish housing system (ESEN, Beijing, China) at 28°C. Embryos were staged as previously described. 27 Tg(fli1:EGFP) y1 transgenic embryos were analyzed as heterozygote and Tg(cmlc2:DsRed2-nuc) f2 and Tg(cmlc2:egfp) transgenic strains were analyzed as homozygote in our studies.
Morpholino and Microinjection
Morpholinos (MOs) were purchased from Gene Tools (Philomath, OR). PAQR10-MO was designed to target the start codon regions +1 to +25 bp with a sequence of 5′-TCCTCCTGAAATCCATACTGTACAT-3′. PAQR10-MO2 is a splice-blocking MO, which targets the exon 4 and intron 4 splice junction of PAQR10 pre-mRNA with sequence 5′-ACACATATCTCACTTACCAGGGTGC-3′. PAQR11-MO and PAQR11-MO2 were designed to target the start codon regions −3 to +22 bp and −59 to −35 bp of zebrafish PAQR11 mRNA, respectively. The sequences are 5′-GAGATGAAGAGGGTGAATAGTTTCC-3′ for PAQR11-MO and 5′-ATCATCCGATTATTTTTGCTGACCC-3′ for PAQR11-MO2. The standard control MO had a sequence of 5′-CCTCTTACCTCAGTTACAATTTATA-3′.
Analyses of Cell Proliferation and Apoptosis in Zebrafish Embryos
The cell proliferation and apoptosis in zebrafish heart ware analyzed, as previously described. 28
Ventricular Contractility Analysis
Ventricular shortening fraction was used to analyze ventricular contractility as previously described. 29 Ventricular shortening fraction=(ventricular length at diastole−ventricular length at systole)/ ventricular length at diastole.
Statistic Analysis
Student t test is used for all of the statistic analyses.
Results

Cloning of Zebrafish PAQR10 and PAQR11
Using the human protein sequences as queries, we performed a translated BLAST search of the zebrafish genome (National Center for Biotechnology Information). As a result, we identified 2 cDNA clones corresponding to mammalian PAQR10 and PAQR11 orthologs in zebrafish (Genbank entry GU556567 for PAQR10 and GU556568 for PAQR11). Zebrafish PAQR10 contains 243 amino acids, which displays 73.2% identity to human PAQR10, whereas zebrafish PAQR11 contains 239 amino acids with 79.9% identity to human PAQR11 ( Figure 1 ). In addition, the cDNAs of zebrafish PAQR10 and PAQR11 are 60.9% identical to each other ( Figure 1 ). Genomic structural analysis revealed that both zebrafish PAQR10 and PAQR11 reside on chromosome 3 with 7 exons, a structure also shared by human PAQR10 and PAQR11.
Expression Profiles of PAQR10 and PAQR11 During Zebrafish Development
To determine the expression patterns of zebrafish PAQR10 and PAQR11 during zebrafish embryogenesis, we carried out whole-mount in situ hybridization with wild-type zebrafish embryos. We found that both of them were widely expressed during early embryogenesis ( Figure 2 ). Zebrafish PAQR10 and PAQR11 are maternally provided, as their mRNAs were detected before onset of zygotic gene expression ( Figure 2A and 2B, at 1-and 4-cell stage). From embryonic day 1 onward, PAQR10 and PAQR11 expression remained ubiquitous, with relative enrichment in the eyes and brain at later stages (Figure 2A and 2B). Zebrafish PAQR11 was expressed in the developing heart, including heart tube at 24 hpf and cardiac chambers at 48 to 72 hpf ( Figure 2B ). However, we could hardly detect expression of zebrafish PAQR10 in the heart (Figure 2A ). Therefore, although the expression patterns of PAQR10 and PAQR11 are highly overlapping during zebrafish embryogenesis, they are not identical in a few regions, especially in the developing heart.
PAQR11 Knockdown Causes Heart Defects During Zebrafish Embryogenesis
To explore the potential physiological function of PAQR10 and PAQR11 in vivo, we used morpholino oligonucleotide (MO) technology to knockdown both genes in zebrafish. We designed 2 PAQR10 MOs with one blocking its translation (PAQR-MO) and another one blocking RNA splicing (PAQR10-MO2) (Figures IA and IIA in the online-only Data Supplement). To partially validate the knockdown efficiency, we constructed a fusion gene between the 5′untranslated region sequence of PAQR10 and the green fluorescent protein (GFP) reporter, drPAQR10-GFP, which includes the targeting sequence of PAQR10-MO. PAQR10-MO was able to abolish the green fluorescence signals generated by drPAQR10-GFP, indicating efficient knockdown of PAQR10 expression by the morpholino ( Figure IB in the online-only Data Supplement). However, PAQR10-MO2 caused a loss of exon 4 of PAQR10 mRNA ( Figure II in the online-only Data Supplement). We also generated 2 MOs specific for zebrafish PAQR11 (PAQR11-MO and PAQR11-MO2), both of which were designed to target the start codon ( Figure IIIA were indistinguishable from control embryos and the blood was flowing normally from the atrium to ventricle at 72 hpf ( Figure 3A ). Studies with PAQR10-MO2 also revealed that PAQR10 knockdown had no apparent effect on zebrafish development ( Figure IV in the online-only Data Supplement).
In contrast to PAQR10 morphants, PAQR11-MO-injected embryos (PAQR11 morphants) appeared indistinguishable from control MO-injected embryos up to 24 hpf, with apparent normal formation of a heart tube ( Figure 3A ). However, by 36 to 48 hpf, although PAQR11 morphants were otherwise morphologically unaltered, they exhibited cardiac dilation and pericardial edema, characteristic of cardiac dysfunction ( Figure 3A ). These cardiac defects became more severe at later stages, and we could clearly observe blood accumulation and regurgitation in the heart at 72 hpf ( Figure 3A; and Movies in the online-only Data Supplement), suggesting disruption of atrioventricular (AV) cushion formation. It is noteworthy that the shape of the outflow tract was not altered by PAQR11 knockdown (data not shown). Histological analyses with sequential sections of zebrafish embryos further revealed blood pooling between atrium and ventricle and a loss of AV cushion in PAQR11 morphants ( Figure 3B ). To further analyze endocardial morphology in vivo, we injected control MO or PAQR11-MO into zebrafish embryos of the transgenic line Tg(fli1:EGFP) Y1,24 in which enhanced green fluorescent protein was expressed in endocardial cells. We examined cardiac formation using in vivo confocal imaging ( Figure  3C ). In control MO-injected embryos, we clearly observed the endocardial rings expressing GFP at the AV boundary at 72 hpf, similar to a previous report. 30 However, injection of PAQR11-MO led to apparently dilated ventricle and atrium, accompanied by a loss of formation of any ring-like structure in the AV boundary ( Figure 3C ).
To validate the specificity of PAQR11-MO, we performed rescue experiments by application of an MO-resistant form of full-length zebrafish PAQR11 mRNA. We found that the heart defects caused by PAQR11-MO were significantly alleviated by the MO-resistant PAQR11 ( Figure VA in the online-only Data Supplement). Moreover, the defects of PAQR11 morphants could be rescued by coinjection of human PAQR11 mRNA ( Figure VA) , indicating a functional conservation of this protein between zebrafish and humans. Furthermore, PAQR11-MO2 morphants also displayed cardiac defects similar to those observed with PAQR11-MO morphants ( Figure  VI in the online-only Data Supplement). Taken together, these observations indicate that PAQR11 plays a critical role in cardiac morphogenesis in zebrafish embryos.
We also analyzed the effect of silencing both PAQR10 and PAQR11 on zebrafish embryos. Injection of PAQR10-MO and PAQR11-MO together led to more severe systemic developmental defects than the injection of PAQR10-MO or PAQR11-MO alone ( Figure VB in the online-only Data Supplement), indicative of a functional redundancy of these 2 proteins. The cardiac developmental defects were also elevated by coinjection of both PAQR10-MO and PAQR11-MO ( Figure VA in the online-only Data Supplement). The functional redundancy of PAQR10 and PAQR11 was also supported by the finding that zebrafish PAQR10 mRNA could significantly rescue the defects caused 
PAQR11 Knockdown Changes the Number and Morphology of Cardiomyocytes During Early Heart Development
As described above, one of the prominent morphological defects in PAQR11 morphant is cardiac dilation. We quantified the sizes of heart in the control and PAQR11 morphants by measuring the cardiac end-diastolic diameter, to further confirm the cardiac dilation phenotype. Consistent with our observations, PAQR11 morphants exhibited significant cardiac dilation at 36 hpf compared with the control morphants, and became more severe at 48 hpf ( Figure 4A ). We also performed a ventricular shortening fraction assay to analyze cardiac contractility. At 36 hpf, the cardiac contractility of the PAQR11 morphants was unaltered ( Figure 4B ). However, the average ventricular shortening fraction of PAQR11 morphants was significantly lower than the controls at 72 hpf ( Figure 4B ). These data suggested that cardiac contractility was also affected in PAQR11-MO-injected embryos.
As dilation of the cardiac chambers in PAQR11 morphants suggests a possible change in number or size of cardiomyocytes, 31 we investigated the number or shape of cardiomyocytes using transgenic zebrafish Tg(cmlc2:DsRed2-nuc) f2 that expressed nuclear DsRed in differentiated cardiomyocytes and Tg(cmlc2:egfp) that has enhanced green fluorescent protein expressed in all cardiac cells. 31 Interestingly, at 48 hpf, the number of cardiomyocytes in PAQR11-MO-injected Tg(cmlc2:DsRed2-nuc) f2 embryos showed a significant reduction when compared with the controls (Figure 4C) .
The finding that the number of cardiomyocytes was reduced by PAQR11-MO prompted us to investigate cell proliferation and apoptosis in zebrafish heart. We investigated the cell proliferation status by measuring the level of phosphorylated histone 3, a marker of mitosis. 28 A terminal deoxynucleotidyl transferase dUTP nick end labeling assay was used to determine cell apoptosis. At 31 hpf, there was no significant alteration in the percentage of phosphorylated histone 3-positive cells upon PAQR11-MO injection (data not shown). Moreover, there was no apoptotic cells observed in the heart of either the control or the PAQR11 morphants at 31 hpf by terminal deoxynucleotidyl transferase dUTP nick end labeling assay (data not shown). However, at 48 hpf, the PAQR11-MO-injected embryos displayed a reduction in the number of proliferating cardiomyocytes, accompanied by an increase in the number of apoptotic cells ( Figure 4D and 4E, upper half). Because the total number of cardiomyocytes in PAQR11 morphants at 48 hpf was reduced compared with the controls (Figure 4C ), we calculated the proliferation/apoptosis index. We found that PAQR11 morphants had a significantly lower proliferative index and higher apoptosis index than the control embryos ( Figure 4D and 4E, lower half). Therefore, the observed reduction of cardiomyocyte number in PAQR11 morphants was likely because of a decreased rate of myocardial cell proliferation together with an increase in myocardial cell apoptosis during early cardiogenesis.
We next examined cardiomyocyte shape in PAQR11 morphants to investigate the possibility that the dilated cardiac chamber could be because of aberrant cell morphologies. We found that in control MO-injected Tg(cmlc2:egfp) embryos, cardiomyocytes were relatively cuboidal with a slightly elongated shape, with the cells being closely adjacent to each other ( Figure 4F ). However, in PAQR11-MO-injected embryos, most cardiomyocytes were extensively elongated ( Figure 4F ). Together, these data suggested that loss of PAQR11 in zebrafish induced a reduction in cardiomyocyte number and aberrant elongation of cardiomyocytes. Furthermore, these defects might account for the subsequent changes in heart development, such as cardiac dilation, defect in heart looping, and disruption of AV development.
Knockdown of PAQR11 Disrupts the Expression of Cardiac Specification Genes
We next examined the expression of a series of cardiac-specific genes to further analyze the effect of PAQR11 knockdown on heart morphogenesis. Expression of the master regulator of early heart development, nkx2.5, 32 was not affected by PAQR11-MO at 13 and 24 hpf ( Figure 5A and 5B ), suggesting that the differentiation of heart progenitor cells at the earliest stage of cardiogenesis was not affected. Cardiac myosin marker my17, which is expressed in all cardiomyocytes, 33 was similar in control and PAQR11 morphants at 48 hpf ( Figure 5C ). Ventricular marker vmhc and atrial marker myh6, 34, 35 however, were expressed in appropriate areas in PAQR11 morphants at 48 hpf ( Figure 5D and 5E). These data indicate that chamber specification and initial differentiation was not defective upon PAQR11 downregulation. However, it was evident that the PAQR11 morphants failed to undergo cardiac looping. In the control embryos, the venous end of the heart was leftward of the midline at 48 hpf whereas the PAQR11 morphants had an unlooped heart tube ( Figure 5C-5E ). In addition, analyses with these markers indicate that PAQR11 knockdown led to severe dilation of cardiac chambers, as the expression of these markers were markedly expanded in both atrium and ventricle ( Figure 5C-5E) .
We also analyzed a series of markers that specify the development of AV canal, including AV canal endocardial marker notch1b and AV canal myocardial markers bmp4 and versican ( Figure 5F-5H) . These AV canal genes are expressed throughout the anteroposterior extent of the heart at the early stage of heart development. 30, 36 By 48 hpf, the expression of these genes became restricted in normal embryos in which notch1b was expressed only in AV canal and outflow tract ( Figure 5F ), bmp4 was expressed in AV canal and inflow tract ( Figure 5G ), and versican was expressed only in AV canal ( Figure 5H ). However, in the heart of PAQR11 morphants at 48 hpf, these genes failed to attain a restricted expression pattern. Both bmp4 and versican were expanded throughout the ventricular portion of the heart ( Figure 5G and 5H) , whereas notch1b was expanded throughout the whole heart ( Figure 5F ). In addition, PAQR11-MO2 also led to abnormal expression patterns of notch1b, bmp4, and versican in the heart at 48 hpf ( Figure  VIB in the online-only Data Supplement).
We also analyzed 2 markers specific for endocardial cushion cells, has2 and spp1. 36, 37 Consistently, the expression of both has2 and spp1 were completely lost at 72 hpf by PAQR11-MO injection ( Figure 5I and 5J) , indicating that the observed AV defect in PAQR11 morphants is not likely caused by a delay in the AV valve formation. Collectively, these results demonstrate that PAQR11 is required for cardiac morphogenesis and AV canal formation during early heart development in zebrafish.
Ras/ERK Signaling Pathway Is Implicated in Heart Morphogenesis in Zebrafish Embryos
Our recent studies have demonstrated that PAQR11 is exclusively located in the Golgi apparatus and is implicated in the spatial regulation of Ras/ERK signaling by tethering Ras proteins to the Golgi apparatus. 21 We also found that PAQR11 is involved in the delayed and prolonged Ras signaling. 21 Therefore, we speculated that PAQR11 might regulate heart morphogenesis through modulation of Ras/ERK signaling in zebrafish. To validate our hypothesis, we extracted proteins from embryos injected with either control MO or PAQR11-MO. We observed that the knockdown of PAQR11 decreased the level of phosphorylated ERK in 72 hpf zebrafish embryos ( Figure 6A and Figure VII in the online-only Data Supplement). In contrast, overexpression of zebrafish PAQR11 mRNA resulted in the elevation of ERK phosphorylation ( Figure 6B) . Therefore, the alterations of ERK phosphorylation by either PAQR11 downregulation or overexpression indicate that PAQR11 plays a role in the regulation of Ras/ERK signaling.
Under such hypothesis, it is expected that PAQR11 knockdown would lead to a downregulation of ERK signaling and that suppression of ERK activation in zebrafish should at least partially phenocopy PAQR11 morphants. To test the hypothesis, we treated 24 hpf zebrafish embryos with MEK inhibitors U0126 and PD98059 to block ERK signaling. Interestingly, both U0126 and PD98059 could cause pericardial edema and abnormal looping defect in zebrafish embryos at 48 hpf in a dose-dependent manner (Figure 6C and 6D) . Furthermore, the defective heart looping caused by MEK inhibitors was confirmed by analyzing the expression pattern of Myl7 (at 48 hpf). In addition, the restricted expression pattern of AV markers notch1b, bmp4 (at 48 hpf), and spp1 (at 72 hpf) was completely disrupted by U0126 and PD98059 ( Figure 6E) , similar to the observations in PAQR11 knockdown ( Figure 5 ). Therefore, these data indicate that inhibition of EKR signaling leads to a similar phenotype as PAQR11 knockdown in zebrafish embryos.
We further analyzed the involvement of Ras-to-ERK signaling pathway in zebrafish heart development by using a The embryos were treated with PD98059 or U0126 at different concentrations as indicated from 24 hpf onward and abnormal heart morphology was counted at 48 hpf. E, Representative whole-mount in situ hybridization (ISH) results for notch1b, bmp4, spp1, and myl7 expression from embryos treated with DMSO, 30 μmol/L PD98059, or 100 μmol/L U0126 (at 48 hpf for notch1b, bmp4, and myl7, and 72 hpf for spp1). The arrow indicates atrioventricular (AV) canal in the heart. F, Morphology (at 72 hpf) of wild-type embryos or those injected with 20 pg of HRasN17 mRNA. The arrow indicates heart edema caused by HRasN17 injection (with 82 of 152 having heart defects). G. Representative whole-mount ISH for my17, notch1b, bmp4, and spp1 expression (at 48 hpf for my17, notch1b, and bmp4; at 72 hpf for spp1) in HRasN17-injected embryos. WT indicates wild type. dominant negative Ras, HRasN17. Intriguingly, injection of HRasN17 mRNA could also lead to cardiac defects at 72 hpf ( Figure 6F ), similar to the observations in PAQR11 morphants and MEK inhibitors. In addition, HRasN17 did not affect heart chamber specification shown as unaffected expression pattern of my17 ( Figure 6G ). However, HRasN17 caused defects in heart looping and AV canal formation shown as a loss of restricted expression patterns of notch1b (at 48 hpf), bmp4 (at 48 hpf), and spp1 (at 72 hpf) ( Figure 6G ), similar to the findings in PAQR11 morphants ( Figure 5 ). In addition to cardiac defects, we observed a defect in the tail region in HRasN17injected embryos ( Figure 6F ), in agreement with a previous report. 38 Therefore, inhibition of Ras-to-ERK signaling either by MEK inhibitors or HRasN17 mRNA injection could recapitulate the cardiac phenotype displayed in PAQR11 morphants, inferring that downregulation of Ras/ERK signaling is implicated in PAQR11-MO-induced heart defects.
Cardiac Defects Caused by PAQR11 Knockdown Are Rescued by Upregulation of Ras Signaling Pathway
To further support the hypothesis that Ras/ERK signaling is implicated in PAQR11-MO-induced cardiac defects, we analyzed whether the defects of PAQR11 morphants could be rescued by upregulation of Ras/ERK signaling. We employed 3 zebrafish HRas variants with different physiological functions (ie, a wild-type HRas, a constitutive active HRas [HRasV12], and a dominant negative HRas [HRasN17]). 39 Immunoblotting results confirmed that injection of HRasV12 could markedly increase the phosphorylation of ERK, whereas HRasN17 inhibited ERK phosphorylation ( Figure 7A ). We found that HRasV12 could significantly reduce the heart defects caused by PAQR11 knockdown (Figure 7B ). The percentage of PAQR11 morphants with apparent heart defect was decreased from ≈0% to ≈33% by coexpression of HRasV12. In addition, overexpression of the wild-type HRas also partially rescued the cardiac defects of PAQR11 morphants ( Figure  7B) . Moreover, the PAQR11-MO-induced alterations in the expression patterns of cardiac specific genes, including myl7 (at 48 hpf), notch1b (at 48 hpf), bmp4 (at 48 hpf), and spp1 (at 72 hpf) were also rescued by coinjection of either HRasV12 or wild-type HRas, but not HRasN17 ( Figure 7C ). Collectively, these data have corroborated our hypothesis that the defects of cardiac morphogenesis in PAQR11 morphants are related to downregulation of Ras/ERK signaling.
Finally, we analyzed whether Golgi-localized Ras could rescue the cardiac defects of PAQR11 morphants. We analyzed the effect of KDELr-RasV12SS (a Golgi-targeted constitutive active Ras) and CD8-RasV12SS (a plasma membranetargeted constitutive active Ras) in zebrafish embryos. 40 Importantly, we found that KDELr-RasV12SS could significantly rescue the heart defects caused by PAQR11 knockdown in zebrafish ( Figure 7D) , with the percentage of embryos having cardiac defects reduced from ≈70% to ≈30%, similar to the rescue efficiency using zebrafish HRasV12 ( Figure  7B ). However, CD8-RasV12SS could not rescue the cardiac defects caused by PAQR11 knockdown (Figure 7D ). Taken together, these results indicate that Ras signaling in the Golgi apparatus, but not at the plasma membrane, is implicated in the biological function of PAQR11 to regulate heart development in zebrafish.
Discussion
In this study, we identified zebrafish orthologs of PAQR10 and PAQR11. Using morpholino technology, we investigated the physiological functions of zebrafish PAQR10 and PAQR11 and found that PAQR11 is implicated in heart morphogenesis during zebrafish development. PAQR10 and PAQR11 are coexpressed in many areas in zebrafish embryos. However, PAQR11 is expressed in the developing heart, whereas the expression of PAQR10 is under a detectable level. Knockdown of PAQR11 in zebrafish embryos exhibited a reduced cardiomyocyte number and exceedingly elongated cardiac cells, leading to defective cardiac formation shown as dilated cardiac chambers, perturbed heart looping, and disrupted endocardial cushion development and AV valve formation. The AV canal defect is confirmed by hematoxylin-eosin staining of sequential sections of zebrafish embryos, as well as confocal images using transgenic line Tg(fli1:EGFP) Y1 . Analyses with an array of cardiac-specific markers, including nkx2. 5, myl7, vmhc, myh6, notch1b, bmp4, versican, has2 , and spp1, further demonstrate that heart looping and AV canal development is disrupted in PAQR11 morphants. The cardiac defects caused by PAQR11 knockdown can be phenocopied by MEK inhibitors and dominant negative HRas. Furthermore, constitutively active HRas and especially a Golgi-localized active Ras is able to rescue the cardiac defects caused by PAQR11 knockdown. Therefore, this study provides the first in vivo evidence that PAQR11 plays a critical role in heart morphogenesis and such function is mediated by the modulation of Ras signaling pathway by PAQR11.
Functional Roles of PAQR11 in Heart Development
The heart development of zebrafish involves several complex and elaborate processes, including the differentiation and migration of the precursor cardiac cells, the formation of the heart tube, the specification of the chambers, the looping, and the ballooning. 1, 2 In PAQR11 morphants, the unaltered expression of nkx2.5 indicates that PAQR11 has no effect on the proliferation, differentiation, and migration of the cardiac precursor cells. Consistently, we observed a normal heart tube formation at 24 hpf, before the onset of cardiac looping and ballooning. Meanwhile, PAQR11 knockdown can not affect chamber specification of atrium and ventricle, as confirmed by the observation that the expression patterns of atrial and ventricular markers, including myl7, vmhc, and myh6, are largely unaltered in PAQR11 morphants.
One of most intriguing findings is that PAQR11 knockdown results in a significantly decreased number of cardiomyocytes by 48 hpf. We also found that the reduction in myocardial cell number is likely caused by a decrease in cell proliferation together with an increase in cell apoptosis. Such findings are consistent with the notion that PAQR11 is implicated in the regulation of Ras signaling and Ras-mediated signaling event is crucial for cell proliferation and apoptosis. In addition, we observed abnormally elongated cardiac cells as early as 36 hpf, suggesting that PAQR11 is required for maintenance of normal cell morphology during heart looping and ballooning.
Interestingly, we found that the abnormally elongated cardiac cells are associated with a reduction in the contractility of the heart. Taken together, we propose that PAQR11 is involved in the proliferation, apoptosis, and morphogenesis of cardiomyocytes in the early stage of heart development and dysregulation of such function by PAQR11 knockdown subsequently leads to other defects such as dilation of cardiac chambers, abnormal heart looping, reduced cardiac contractility, and defects in endocardial cushion development. Furthermore, as PAQR11 is involved in Golgi-mediated Ras signaling, 21 our study also indicates that the Golgi-mediated and -delayed Ras signaling is specifically required for the proper functioning of cardiomyocytes during early heart development.
Functional Difference and Redundancy Between PAQR10 and PAQR11
It is noteworthy that PAQR10 and PAQR11 are 2 highly homologous proteins and may have a redundant physiological Figure 7 . Cardiac defects caused by progesterone and adipoQ receptor (PAQR) 11 knockdown is rescued by upregulation of Ras signaling. A, Zebrafish embryos were injected with PAQR11 morpholino oligonucleotide (MO) and various forms of HRas mRNA as indicated (4 ng for PAQR11-MO, 5 pg for wild-type HRas, 1 pg for HRasV12, and 5 pg for HRasN17). The embryos were analyzed at 72 hpf and those with apparent heart malformation were counted. Three independent experiments were performed for each injection (PAQR11-MO, n=566; PAQR11-MO and HRasV12, n=414; PAQR11-MO and wild-type HRas, n=391; PAQR11-MO and HRasN17, n=367). The data are shown as mean±SD as compared with the group injected with PAQR11-MO alone. B, Representative whole-mount in situ hybridization for my17, notch1b, bmp4, and spp1 expression (at 48 hpf for my17, notch1b, and bmp4; at 72 hpf for spp1) for each group. The arrow indicates atrioventricular canal. C, Cardiac defects induced by PAQR11-MO is rescued by a Golgi-targeted constitutively active Ras. Zebrafish embryos were injected with PAQR11-MO (4 ng) and various forms of Ras mRNA as indicated (20 pg for KDELr-HRasV12SS and 40 pg for CD8-HRasV12SS). The embryos were analyzed at 72 hpf and those with apparent blood regurgitation were counted as having heart developmental defect. D, Three independent experiments were performed (PAQR11-MO, n=566; PAQR11-MO and KDELr-HRasV12, n=255; PAQR11-MO and CD8-HRasV12, n=320) and the data are shown as mean±SD. ERK indicates extracellular signal-regulated kinase.
function. Biochemical analyses indicate that both mammalian PAQR10 and PAQR11 have a redundant function in mediating Golgi-restricted Ras signaling in mammalian cells. 21 Both zebrafish PAQR10 and PAQR11 are ubiquitously expressed during zebrafish early development (Figure 2 ). The functional redundancy of these 2 proteins is supported by the findings that both the systemic and cardiac defects are increased by injection of both PAQR10-MO and PAQR11-MO ( Figure V in the onlineonly Data Supplement). It is also noteworthy that PAQR10 mRNA could significantly rescue the defects caused by PAQR11 knockdown (Figure V in the online-only Data Supplement), likely because of the ectopic expression of injected PAQR10 in the heart. As PAQR11 is expressed in the developing heart while the expression of PAQR10 is hardly detectable, the slight difference in the expression patterns of PAQR10 and PAQR11 especially in the developing heart may explain why knockdown of PAQR11 but not PAQR10 induces cardiac defects in zebrafish. We, therefore, propose that the physiological activities of these 2 genes are most likely dependent on their expression patterns in different tissues and at different developmental stages.
Ras Signaling Pathway in Heart Development
Our study has substantiated the importance of Ras signaling in heart development. The involvement of Ras-related signaling in congenital heart disease has been underscored recently by many studies. Numerous genes involved in Ras/ ERK signaling pathway were discovered to be affected in human congenital heart disease. Activating mutations of the tyrosine phosphatase SHP2, HRas, B-Raf, and MEK1/2 were found in Noonan syndrome, Costello syndrome, and cardiofaciocutaneous syndrome. 10, [41] [42] [43] [44] [45] The common features of these syndromes, include hypertrophic cardiomyopathy, electrophysiological abnormalities, and septal defects. 46 Although a gain-of-function mutation of Ras signaling is believed to be the underlying mechanism for congenital heart disease, emerging evidence from clinical and genetic studies have revealed that downregulation of Ras/ERK singling is also associated with cardiac defects during development. LEOPARD syndrome shares multiple phenotypic features, including cardiac defects found in Noonan syndrome. The SHP2 mutations found in LEOPARD syndrome have a dominant negative effect to inhibit Ras/ERK signaling. 47 Furthermore, embryos with morpholino knockdown of Raf1, a downstream effector of Ras, developed enlarged heart tube and perturbed heart looping. 10 In addition, mice with deletion of protein-tyrosine phosphatase, nonreceptor type 11, specifically, in cardiomyocytes developed dilated cardiomyopathy through Ras/ERK and RhoA signaling pathways. 47 Therefore, these studies suggest that impaired Ras/ ERK signaling is also able to cause defects in heart development. In this study, we found that PAQR11 may affect heart morphogenesis through downregulation of Ras/ERK signaling. Knockdown of PAQR11 reduces ERK phosphorylation in zebrafish embryos, whereas overexpression of PAQR11 leads to an increase of ERK phosphorylation. Inhibition of Ras/ERK signaling by MEK inhibitors or a dominant negative Ras is able to recapitulate the cardiac defects caused by PAQR11 knockdown. Most importantly, only a Golgi-targeted constitutively active Ras, but not a plasma membrane-targeted constitutively active Ras, can rescue the cardiac defects caused by PAQR11 knockdown ( Figure 7D ). Therefore, our study has provided a new piece of evidence demonstrating that downregulation of Ras/ERK signaling imposed by PAQR11 knockdown is linked to cardiac developmental defects. Considering the importance of PAQR11 in early heart development, it will be important to identify in the future whether alteration or mutation of PAQR11 is associated with congenital heart diseases in humans.
